TrialMultiple sclerosis (Houndmills, Basingstoke, England)2016

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.

Ayman Tourbah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.